Real-World Effectiveness and Safety of Fingolimod in Patients With Relapsing Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina
Conclusions
The effectiveness of fingolimod in a newly real-world setting was consistent with information provided from phase III clinical trials.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research
More News: Argentina Health | Brain | Clinical Trials | Disability | Gilenya | MRI Scan | Multiple Sclerosis | Neurology | Study